Contraceptive use by Iranian women with hypertension, diabetes or obesity

Nojomi, M.; Morrovatdar, N.; Davoudi, Farnoush; Hosseini, Seyed Mehran

doi:10.26719/2013.19.7.638

Cited by 8 publications

(11 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Similar findings and low use of modern contraceptive methods with women mainly using coital withdrawal method were found in Iranian women with type 2 DM, hypertension, or obesity. 15 Although the results of these studies may not be generalizable to different demographic communities, the importance of educating women with DM from all groups of society needs to be emphasized.…”

Section: Methodsmentioning

confidence: 99%

“…The prevalence of DM is rising rapidly in the Middle Eastern countries and the developing world, 2 and two studies from Iran have identified low use of contraception by women with DM. 14 , 15 A mixed method cross-sectional study involving 200 women identified many pregnancy-related abnormalities and a lack of confidence in using contraceptives, with many women not using any form of contraception. Similar findings and low use of modern contraceptive methods with women mainly using coital withdrawal method were found in Iranian women with type 2 DM, hypertension, or obesity.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Contraception for women with diabetes: challenges and solutions

Robinson

Nwolise

Shawe

2016

OAJC

View full text Add to dashboard Cite

Diabetes mellitus (DM), the most common of metabolic disorders, is a global public health concern. Numbers are rising with 383 million adults currently diagnosed with DM and another 175 million as yet undiagnosed. The rise in cases includes increasing numbers of women of a reproductive age whose reproductive health and contraception need careful consideration. Unintended pregnancy with poor glycemic control at the time of conception increases the chance of adverse pregnancy outcomes including stillbirth, congenital abnormalities, and perinatal mortality. In order to minimize complications, safe and effective contraception is paramount for all women with DM. This is a challenge as women have been found to be reticent to ask for advice, appear to lack understanding of risks, and are less likely to be using contraception than women without DM. The World Health Organization has developed Medical Eligibility Criteria to guide contraceptive choice. Women with DM without complications can choose from the full range of contraceptive methods including hormonal contraception as the advantages of use outweigh any risk. Women with diabetic complications may need specialist advice to assess the risk–benefit equation, particularly in respect of hormonal contraception. Women should be aware that there is no restriction to the use of oral and copper intrauterine emergency contraception methods. There is a need for an integrated approach to diabetes and reproductive health with improved communication between women with DM and their health care providers. Women need to be aware of advice and services and should make their own choice of contraception based on their needs and associated risk factors. Practitioners can offer nonjudgmental guidance working in partnership with women. This will enable discussion of risks and benefits of contraceptive methods and provision of advice dedicated to improving overall health and well-being.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Contraception for women with diabetes: challenges and solutions

Robinson

Nwolise

Shawe

2016

OAJC

View full text Add to dashboard Cite

show abstract

“…Hasil penelitian White, K., et al (2013) di El Paso (Texas), menemukan 7% pengguna kontrasepsi suntikan dan 10,5% pengguna oral kontrasepsi mengalami hipertensi. Nojomi, M., et al (2013) menemukan 31,5% wanita Iran yang menggunakan kontrasepsi mengalami hipertensi. Murayama, M., et al (2013) yang melakukan penelitian di Thailand juga menemukan bahwa wanita yang menggunakan kontrasepsi pil memiliki tekanan darah lebih tinggi daripada wanita yang tidak pernah menggunakannya.…”

Section: Kataunclassified

Hubungan Penggunaan Kontrasepsi Hormonal Dengan Kejadian Hipertensi Pada Wanita Usia Reproduktif (15-49 Tahun) Di Wilayah Kerja Puskesmas Teladan Kota Medan Tahun 2019

Manik¹,

Ambarita²

2020

JMU

View full text Add to dashboard Cite

Background: The prevalence of hypertension in Indonesia continues to increase, especially in women. The incidence rate reached 28.8% higher than the incidence of hypertension in men which is 22.8%. There are factors that make women more at risk of hypertension than men. Namely the use of hormonal contraception in women whose users reach 47.54%. Purpose: to analysis Correlational hormonal contraceptive use and hypertension. Methods: This research is an observational survey research, case-control design. Held in the Work Area of the Medan City Primary Health Center. Conducted from March-June 2019. The population were all women of productive age (15-49 years) totaling 572 people. The size of the case sample was 35 people and 35 controls. Case samples were taken by means of consecutive sampling, control samples were taken by convenient sampling. Data analysis was performed univariately and bivariately using the Chi Square statistical test (?2) with a significance level of 0.05. Results: In the hypertension group, 77.1% used hormonal contraception and 22.9% did not use hormonal contraception. Whereas in the non hypertensive group 62.9% did not use hormonal contraception only 37.1% used hormonal contraception. There is a relationship between hormonal contraceptive use and hypertension in women of reproductive age. A value (OR = 5.7; 95% CI 2,008-16,244) means that women of reproductive age are at risk of experiencing hypertension 5.7 times greater if women of reproductive age use hormonal contraception than those who do not use hormonal contraception. Conclusion: Women of reproductive age are at risk of developing hypertension when using hormonal contraception. Therefore, it is recommended that women of reproductive age prefer non-hormonal contraception or natural contraception. If using hormonal contraception to keep monitoring blood pressure regularly at least 3 months after using hormonal contraception and immediately stop using hormonal contraception if there is a hypertension Keyword: Hormonal contraception; Hypertension; Women at Reproductive age

show abstract

“…A limited number of studies explored contraception use among women with diabetes and hypertension. Also, the ndings are inconclusive due to substantial variation in study designs, sample sizes, and the number of chronic conditions as explanatory variables [9][10][11][12][13][14]. Furthermore, patterns of contraception use among women with diabetes and hypertension were not compared with women without such conditions [14].…”

Section: Introductionmentioning

confidence: 99%

Association Between Contraception Use, Diabetes and Hypertension: Findings from Bangladesh Demographic and Health Survey

Khan

Islam

2022

Preprint

View full text Add to dashboard Cite

Background: The prevalence of chorionic conditions such as diabetes and hypertension is increasing among reproductive-aged women in Bangladesh. Pregnancy in women with uncontrolled chronic conditions may increase the risks of adverse consequences, including maternal and child morbidity and mortality. Appropriate contraception use can help women to prevent pregnancy until women have controlled chronic conditions and reduce the risks of adverse maternal and child health consequences. We investigate the associations between diabetes and/or hypertension and contraception use among reproductive-aged women in Bangladesh.Methods: We analysed data of 3,947 women, extracted from the 2017/18 Bangladesh Demographic and Health Survey. Women’s contraception using patterns were our outcome variable, which was classified as (i) any contraception method use vs no use, (ii) modern methods vs traditional methods or no use, (iii) modern methods vs traditional methods use. The explanatory variables were diagnosis of diabetes only, hypertension only or both diabetes and hypertension. The multilevel Poisson regression with robust variance was used to explore the associations.Results The overall prevalence of contraception use was 68.0% (95% CI: 66.3-69.7), 69.4% (95% CI: 61.8-76.1) in women with diabetes only, 67.3% (95% CI: 63.5-70.9) with hypertension only, and 62.0% (95% CI: 52.8-70.4) in women having both diabetes and hypertension. The prevalence of modern methods of contraception use was lower (46.4%, 95% CI: 37.4-55.6) and traditional methods use higher (16.6%, 95% CI: 13.8-16.8) in women who had both diabetes and hypertension than women who did not have these conditions. The fully adjusted regression model showed that the prevalence of traditional method use was 31% (95% CI: 1.02-2.01) higher in women having both diabetes and hypertension compared with their counterparts who had none of these conditions. Conclusion: In Bangladesh, women with both diabetes and hypertension were more likely to use traditional contraception methods. These women are likely to experience increased risks of unwanted pregnancies and associated adverse maternal and child health outcomes.

show abstract

Contraceptive use by Iranian women with hypertension, diabetes or obesity

Cited by 8 publications

References 17 publications

Contraception for women with diabetes: challenges and solutions

Contraception for women with diabetes: challenges and solutions

Hubungan Penggunaan Kontrasepsi Hormonal Dengan Kejadian Hipertensi Pada Wanita Usia Reproduktif (15-49 Tahun) Di Wilayah Kerja Puskesmas Teladan Kota Medan Tahun 2019

Association Between Contraception Use, Diabetes and Hypertension: Findings from Bangladesh Demographic and Health Survey

Contact Info

Product

Resources

About